Manufacturer of Controlled Substances; Notice of Application, 57080 [2011-23617]
Download as PDF
<![CDATA[
57080
Federal Register / Vol. 76, No. 179 / Thursday, September 15, 2011 / Notices
after the case is closed, in accordance
with the Records Disposition Authority
NC1–204–95–1, or successor Records
Disposition Authority.
All records within ECRD are
maintained within the system while a
clemency petition is pending and for
fifteen years after the year in which the
case was closed. Copies of all records
pertaining to cases closed in the
previous calendar year contained within
the system are sent to NARA on an
annual basis. OPA maintains legal
custody of these records until fifteen
years have elapsed, at which point the
records within ECRD are destroyed and
NARA becomes the legal custodian of
the records. This change occurs in
accordance with Records Disposition
Authority DA–204–2011–0001 or
successor Records Disposition
Authority.
SYSTEM MANAGER(S) AND ADDRESS:
Pardon Attorney, Office of the Pardon
Attorney, U.S. Department of Justice,
Washington, DC 20530.
NOTIFICATION PROCEDURE:
Address inquiries to the Pardon
Attorney, Office of the Pardon Attorney,
U.S. Department of Justice, Washington,
DC 20530, or e-mail inquiries to
USPardon.Attorney@usdoj.gov.
wreier-aviles on DSKGBLS3C1PROD with NOTICES
RECORD ACCESS PROCEDURES:
The Attorney General has exempted
executive clemency records from
various provisions of the Privacy Act,
including the access and amendment
provisions, to the extent such
exemptions apply pursuant to 5 U.S.C.
552a(j)(2). Where compliance would not
appear to interfere with or adversely
affect the purposes of the system or the
law enforcement process, the applicable
exemption (in whole or in part) may be
waived by the OPA in its sole
discretion. These requests for
discretionary releases of records shall be
made either in writing or via email to
the system manager listed above with
the envelope and letter or subject line
clearly marked ‘‘Privacy Access
Request.’’ Include in the request the
general subject matter of the document.
Provide full name, current address, date
and place of birth, signature, all of
(which must be either be notarized or
submitted under penalty of perjury),
and a return address or email address
for transmitting the information.
CONTESTING RECORD PROCEDURES:
Same as Record Access Procedures.
RECORD SOURCE CATEGORIES:
Sources of information include:
individual applicants for clemency,
their representatives, and persons who
VerDate Mar<15>2010
15:07 Sep 14, 2011
Jkt 223001
write, confer with, or orally advise OPA
concerning those applicants;
investigatory reports of the Federal
Bureau of Investigation, the Drug
Enforcement Administration, the
Internal Revenue Service, Immigration
and Customs Enforcement agency of the
Department of Homeland Security and
other appropriate government agencies;
records of the Federal Bureau of Prisons;
reports of the Armed Forces;
presentence reports provided by the
Bureau of Prisons or the federal
Probation Offices; reports of the U.S.
Parole Commission; data provided by
the Office of White House Counsel;
comments and recommendations from
current and former federal and state
officials; and employees of the
Department of Justice.
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 952(a)
and 958(a), and in accordance with 21
CFR 1301.34, the above named company
is granted registration as an importer of
the basic class of controlled substance
listed.
Dated: September 9, 2011.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2011–23620 Filed 9–14–11; 8:45 am]
BILLING CODE 4410–09–P
EXEMPTIONS CLAIMED FOR THE SYSTEM:
The Attorney General has exempted
this system from subsections (c)(3),
(c)(4), (d)(1), (d)(2), (d)(3), (d)(4), and
(e)(5) of the Privacy Act pursuant to 5
U.S.C. 552a(j)(2). Rules have been
promulgated in accordance with the
requirements of 5 U.S.C. 553 (b), (c), and
(e) and have been published in the
Federal Register.
[FR Doc. 2011–23599 Filed 9–14–11; 8:45 am]
BILLING CODE 4410–29–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Registration
By Notice dated June 7, 2011, and
published in the Federal Register on
June 16, 2011, 76 FR 35239, Noramco
Inc., 1440 Olympic Drive, Athens,
Georgia 30601, made application by
letter to the Drug Enforcement
Administration (DEA) to be registered as
an importer of Phenylacetone (8501), a
basic class of controlled substance listed
in schedule II.
The company plans to import the
listed controlled substance in bulk for
the manufacture of a controlled
substance.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and 952(a)
and determined that the registration of
Noramco Inc. to import the basic class
of controlled substance is consistent
with the public interest, and with
United States obligations under
international treaties, conventions, or
protocols in effect on May 1, 1971. DEA
has investigated Noramco Inc. to ensure
that the company’s registration is
consistent with the public interest. The
investigation has included inspection
PO 00000
Frm 00064
Fmt 4703
Sfmt 9990
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Application
Pursuant to § 1301.33(a), Title 21 of
the Code of Federal Regulations (CFR),
this is notice that on August 3, 2011,
Chemic Laboratories, Inc., 480 Neponset
Street, Building 7, Canton,
Massachusetts 02021, made application
by renewal to the Drug Enforcement
Administration (DEA) to be registered as
a bulk manufacturer of Cocaine (9041),
a basic class of controlled substance
listed in schedule II.
The company plans to manufacture
small quantities of the above listed
controlled substance for distribution to
its customers for the purpose of
research.
Any other such applicant, and any
person who is presently registered with
DEA to manufacture such substance,
may file comments or objections to the
issuance of the proposed registration
pursuant to 21 CFR 1301.33(a).
Any such written comments or
objections should be addressed, in
quintuplicate, to the Drug Enforcement
Administration, Office of Diversion
Control, Federal Register Representative
(ODL), 8701 Morrissette Drive,
Springfield, Virginia 22152; and must be
filed no later than November 14, 2011.
Dated: September 9, 2011.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2011–23617 Filed 9–14–11; 8:45 am]
BILLING CODE 4410–09–P
E:\FR\FM\15SEN1.SGM
15SEN1
]]>Agencies
[Federal Register Volume 76, Number 179 (Thursday, September 15, 2011)]
[Notices]
[Page 57080]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-23617]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Application
Pursuant to Sec. 1301.33(a), Title 21 of the Code of Federal
Regulations (CFR), this is notice that on August 3, 2011, Chemic
Laboratories, Inc., 480 Neponset Street, Building 7, Canton,
Massachusetts 02021, made application by renewal to the Drug
Enforcement Administration (DEA) to be registered as a bulk
manufacturer of Cocaine (9041), a basic class of controlled substance
listed in schedule II.
The company plans to manufacture small quantities of the above
listed controlled substance for distribution to its customers for the
purpose of research.
Any other such applicant, and any person who is presently
registered with DEA to manufacture such substance, may file comments or
objections to the issuance of the proposed registration pursuant to 21
CFR 1301.33(a).
Any such written comments or objections should be addressed, in
quintuplicate, to the Drug Enforcement Administration, Office of
Diversion Control, Federal Register Representative (ODL), 8701
Morrissette Drive, Springfield, Virginia 22152; and must be filed no
later than November 14, 2011.
Dated: September 9, 2011.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2011-23617 Filed 9-14-11; 8:45 am]
BILLING CODE 4410-09-P
